Newsroom | 62015 results

BEIJING--(BUSINESS WIRE)--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced it has filed its definitive proxy materials with the Securities and Exchange Commission (SEC) for the Special Meeting of Shareholders to be held on Wednesday, July 9, 2025 at 8:00 a.m. China Standard Time (Tuesday, July 8, 2025 at 8:00 p.m. Atlantic Standard Time). In conjunction with the filing of the def...

HAUPPAUGE, N.Y.--(BUSINESS WIRE)--Saptalis Pharmaceuticals, LLC. is pleased to announce the commercial launch of Fluoxetine Oral Solution, USP 20 mg/5 mL, a prescription-only selective serotonin reuptake inhibitor (SSRI) developed to treat a range of mental health conditions effectively. This oral formulation is designed to support flexible and individualized treatment, particularly for patients who experience difficulty swallowing solid dosage forms. Fluoxetine Oral Solution is indicated for t...

HYOGO, Japan--(BUSINESS WIRE)--JCR announced the launch of a film featured in The Next Frontier, a series presented by BIO and produced by BBC StoryWorks Commercial Productions....

PORTLAND, Ore.--(BUSINESS WIRE)--Diabetomics has been rebranded Modality Dx. Founded by Dr. Srinivasa Nagalla, Modality Dx is an innovator in rapid test technologies for risk assessment and diagnosis in maternal health, diabetes and autoimmune disease. “Throughout my career, I’ve seen firsthand the great need for more preventive healthcare solutions,” said Dr. Nagalla. “Too often doctors see patients after disease has already taken hold. My goal is to develop diagnostic tools that can assist in...

SAN FRANCISCO--(BUSINESS WIRE)--Abridge, a leading generative AI platform for clinical conversations, is expanding its capabilities to support inpatient care settings and queue up outpatient orders—extending the value of clinical conversations through additional integrated workflows as part of Workshop, a program through which Epic and Abridge have worked together to develop new, innovative healthcare technologies that are piloted and refined before wider release. These new offerings are alread...

SALT LAKE CITY--(BUSINESS WIRE)--Xlear Sues FTC for Unlawful Scientific Censorship; FTC’s marketing substantiation rules violate Supreme Court Loper Ruling...

CANNES, France & NEW YORK--(BUSINESS WIRE)--21GRAMS Named No. 2 Healthcare Agency and Real Chemistry Ranked No. 2 Healthcare Network at Cannes Lions International Festival of Creativity...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNA interference (RNAi) therapeutics company, today announced that Pushkal Garg, M.D., has been appointed Executive Vice President, Chief Research and Development Officer to oversee an integrated R&D organization. Building on the launch of AMVUTTRA® in transthyretin amyloidosis with cardiomyopathy (ATTR-CM), Alnylam is entering a new phase of growth, and a combined R&D organization will accelera...

LOS ANGELES--(BUSINESS WIRE)--mPulse, a leading provider of Health Experience and Insights (HXI) technology, today announced details for Activate2025, the company’s industry conference for healthcare executives to learn, network, and celebrate innovative health engagement. This year’s event will convene healthcare and technology thought leaders in Austin, Texas from September 23-24, 2025. The company also announced renowned 2025 keynote speakers, Chiquita Brooks-LaSure and Kate O’Neill, who wil...

PLEASANTON, Calif.--(BUSINESS WIRE)--Charm Health's annual competition invites innovators, entrepreneurs & developers to shape the future of digital health with cutting-edge tech & AI....